Janjigian YY - Search Results

1

Distinct clinical course of EGFR-mutant resected lung cancers: results of testing of 1118 surgical specimens and effects of adjuvant gefitinib and erlotinib.

D'Angelo SP, Janjigian YY, Ahye N, Riely GJ, Chaft JE, Sima CS, Shen R, Zheng J, Dycoco J, Kris MG, Zakowski MF, Ladanyi M, Rusch V, Azzoli CG. D'Angelo SP, et al. Among authors: janjigian yy. J Thorac Oncol. 2012 Dec;7(12):1815-1822. doi: 10.1097/JTO.0b013e31826bb7b2. J Thorac Oncol. 2012. PMID: 23154553 Free article.

2

[No title available]

[No authors listed] [No authors listed] PMID: 36919706

3

A phase I trial of SJG-136 (NSC#694501) in advanced solid tumors.

Janjigian YY, Lee W, Kris MG, Miller VA, Krug LM, Azzoli CG, Senturk E, Calcutt MW, Rizvi NA. Janjigian YY, et al. Cancer Chemother Pharmacol. 2010 Apr;65(5):833-8. doi: 10.1007/s00280-009-1088-4. Epub 2009 Aug 12. Cancer Chemother Pharmacol. 2010. PMID: 19672598 Free PMC article. Clinical Trial.

4

Pack-years of cigarette smoking as a prognostic factor in patients with stage IIIB/IV nonsmall cell lung cancer.

Janjigian YY, McDonnell K, Kris MG, Shen R, Sima CS, Bach PB, Rizvi NA, Riely GJ. Janjigian YY, et al. Cancer. 2010 Feb 1;116(3):670-5. doi: 10.1002/cncr.24813. Cancer. 2010. PMID: 20029977 Free PMC article.

5

Efficacy and safety of bevacizumab in active brain metastases from non-small cell lung cancer.

De Braganca KC, Janjigian YY, Azzoli CG, Kris MG, Pietanza MC, Nolan CP, Omuro AM, Holodny AI, Lassman AB. De Braganca KC, et al. Among authors: janjigian yy. J Neurooncol. 2010 Dec;100(3):443-7. doi: 10.1007/s11060-010-0200-2. Epub 2010 May 4. J Neurooncol. 2010. PMID: 20440540 Free PMC article.

6

Impact on disease-free survival of adjuvant erlotinib or gefitinib in patients with resected lung adenocarcinomas that harbor EGFR mutations.

Janjigian YY, Park BJ, Zakowski MF, Ladanyi M, Pao W, D'Angelo SP, Kris MG, Shen R, Zheng J, Azzoli CG. Janjigian YY, et al. J Thorac Oncol. 2011 Mar;6(3):569-75. doi: 10.1097/JTO.0b013e318202bffe. J Thorac Oncol. 2011. PMID: 21150674 Free PMC article.

7

Phase I/II trial of cetuximab and erlotinib in patients with lung adenocarcinoma and acquired resistance to erlotinib.

Janjigian YY, Azzoli CG, Krug LM, Pereira LK, Rizvi NA, Pietanza MC, Kris MG, Ginsberg MS, Pao W, Miller VA, Riely GJ. Janjigian YY, et al. Clin Cancer Res. 2011 Apr 15;17(8):2521-7. doi: 10.1158/1078-0432.CCR-10-2662. Epub 2011 Jan 19. Clin Cancer Res. 2011. PMID: 21248303 Clinical Trial.

8

MET expression and amplification in patients with localized gastric cancer.

Janjigian YY, Tang LH, Coit DG, Kelsen DP, Francone TD, Weiser MR, Jhanwar SC, Shah MA. Janjigian YY, et al. Cancer Epidemiol Biomarkers Prev. 2011 May;20(5):1021-7. doi: 10.1158/1055-9965.EPI-10-1080. Epub 2011 Mar 10. Cancer Epidemiol Biomarkers Prev. 2011. PMID: 21393565 Free PMC article.

9

Maintained sensitivity to EGFR tyrosine kinase inhibitors in EGFR-mutant lung cancer recurring after adjuvant erlotinib or gefitinib.

Oxnard GR, Janjigian YY, Arcila ME, Sima CS, Kass SL, Riely GJ, Pao W, Kris MG, Ladanyi M, Azzoli CG, Miller VA. Oxnard GR, et al. Among authors: janjigian yy. Clin Cancer Res. 2011 Oct 1;17(19):6322-8. doi: 10.1158/1078-0432.CCR-11-1080. Epub 2011 Aug 10. Clin Cancer Res. 2011. PMID: 21831955 Free PMC article.

10

Tobacco use is associated with increased recurrence and death from gastric cancer.

Smyth EC, Capanu M, Janjigian YY, Kelsen DK, Coit D, Strong VE, Shah MA. Smyth EC, et al. Among authors: janjigian yy. Ann Surg Oncol. 2012 Jul;19(7):2088-94. doi: 10.1245/s10434-012-2230-9. Epub 2012 Mar 7. Ann Surg Oncol. 2012. PMID: 22395977 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

172 results

Search Page

Filters